He & She MD vs RxActivate: Pricing, Coaching, and Eligibility Compared
He & She MD vs RxActivate is a direct choice between a transparent, bundled GLP-1 program and a clinician-matched flow that hides price until eligibility is verified. Quick verdict: He & She MD publishes starting prices and bundles a coaching app with 1:1 clinician messaging, while RxActivate requires a completed eligibility questionnaire and contact details before revealing plan pricing or fees.
See He & She MD starting plans
Key differences at a glance: He & She MD vs RxActivate
Comparing these providers side by side highlights a few decisive distinctions: pricing visibility and structure, bundled coaching and clinician access, medication formats and regulatory notes, eligibility and lead capture, and shipping or fee disclosures. Each section below uses only supplied facts.
1. Pricing visibility and structure
He & She MD: Semaglutide injections start at $139/month and oral semaglutide and tirzepatide injections start at $199/month as six-month introductory rates. The landing page repeatedly notes these are six-month promos that renew higher. RxActivate: No price, medication fee, membership fee, shipping charge, cancellation term or billing commitment was displayed before the contact-information gate. Pricing is therefore gated behind the eligibility flow.
2. Bundled coaching and clinician access
He & She MD: Every plan bundles the He & She MD app with 1:1 clinician messaging, GLP-1-specific coaching and progress tracking at no extra cost. RxActivate: Describes clinician-matched GLP-1 plans and state and medical-safety screening but does not show bundled coaching or app features on the captured pages.
Start RxActivate eligibility quiz
3. Medication formats and regulatory notes
He & She MD: Offers compounded semaglutide injection, oral semaglutide, and tirzepatide injection. The provider states medications are produced in USP-compliant, state-regulated pharmacies but are compounded and not reviewed by the FDA for safety, efficacy, or quality. RxActivate: Notes that when compounded medications are offered, they are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both providers include regulatory qualifiers and require clinician prescription where applicable.
4. Eligibility flow and lead capture
He & She MD: Intake is described as a fast 2-3 minute process with no payment required to check eligibility. RxActivate: Uses a two-minute eligibility questionnaire that requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening. The RxActivate flow displayed likely eligibility then required first name, last name, email and phone number before revealing any plan or price. Alabama service availability was confirmed in the synthetic test captured.
5. Shipping, fees and transparency
He & She MD: Advertises free expedited shipping, no membership fee, and no insurance required. The company clarifies headline prices are promo six-month rates that renew at higher six-month prices. RxActivate: Did not display shipping, medication, membership or cancellation fees before the contact-information gate, so those details must be confirmed during the eligibility flow.
| Criteria | He & She MD | RxActivate |
|---|---|---|
| Starting price shown | Semaglutide from $139/mo; oral and tirzepatide from $199/mo (six-month intro) | Not shown before eligibility and contact-information gate |
| Coaching and clinician access | App with 1:1 clinician messaging and GLP-1 coaching included | Clinician-matched plans; bundled coaching not shown in captured evidence |
| Medication formats | Semaglutide injection, oral semaglutide, tirzepatide injection | Clinician-matched medication options; specifics gated behind intake |
| Regulatory note | Compounded meds produced in USP-compliant pharmacies; not reviewed by FDA | When compounded, not FDA-approved and not reviewed by FDA for safety or effectiveness |
| Eligibility flow | Fast 2-3 minute intake; no payment required to check eligibility | Two-minute questionnaire; requires contact info before price and plan details |
| Shipping and fees shown | Free expedited shipping; no membership fee; no insurance needed | No shipping or fee details shown before contact-information gate |
What to know about terms, renewals and qualifying
He & She MD repeatedly warns that headline prices are six-month introductory rates that renew at higher six-month prices. Medications require consultation and prescription by a clinician through the He & She MD platform and not all customers will qualify for a prescription. RxActivate emphasizes that treatment is available only when a licensed clinician determines it is medically appropriate and that pricing and eligibility are subject to the live offer revealed after the eligibility flow.
Complete RxActivate quiz to view plans
View He & She MD program details
Bottom line: He & She MD vs RxActivate
He & She MD provides visible starting prices, clearly described six-month introductory rates, and a bundled coaching app with 1:1 clinician messaging and progress tracking. RxActivate uses a clinician-matched eligibility flow that confirms likely eligibility then requires contact details before disclosing price, fees, or specific plan terms. Both note that compounded medications are not reviewed by the FDA when offered and that clinician review determines medical appropriateness.
Choose He & She MD if you want published starting prices, a bundled GLP-1 coaching app with 1:1 clinician messaging, free expedited shipping, and clear six-month introductory rates that explicitly renew at higher terms.
Choose RxActivate if you prefer to confirm medical eligibility, state availability and pricing only after completing a clinician-matching questionnaire and providing contact information so a live offer can be revealed.